fr en es de it pt nl

Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie

Ergebnis Ihrer Suche : 16 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD

Unconjugated 16

Inhibitor/Antagonist/Agonist

FILTER ANWENDEN
REINITIALISIEREN

Katalog-Nummer

Beschreibung

Cond.

Preis zzgl. MwSt.

orb1910546-250mg

FY-21 is a selective inhibitor of LSD1.

250mg

orb1910546-1g

FY-21 is a selective inhibitor of LSD1.

1g

orb1910546-100mg

FY-21 is a selective inhibitor of LSD1.

100mg

orb1909814-250mg

Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]

250mg

orb1909814-1g

Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]

1g

orb1909814-100mg

Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. [[1808113-09-8]]

100mg

orb1910252-1g

J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]

1g

orb1910252-250mg

J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]

250mg

orb1910252-100mg

J 3-54 , also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. VUN34592 can mediate the expression of PD-L1, enhance T cell killing response, and can be used in cancer research. [[4734-59-2]]

100mg

orb1910516-1g

HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]

1g

orb1910516-100mg

HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]

100mg

orb1910516-250mg

HDAC-IN-57 is an orally active inhibitor of histone deacetylases (HDAC), with IC50s of 2.07 nM, 4.71 nM, 2.4 nM and 107 nM for HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-57 can inhibits LSD1, with IC50 of 1.34 μΜ. HDAC-IN-57 induces apoptosis, and has anti-tumor activity[1]. [[2716217-79-5]]

250mg

217521-10mg

LSD1 Inhibitor IV, RN-1,HCl (2-(1R,2S)-2-(4-(Benzyloxy)phenyl)cyclopropylamino)-1-(4-methylpiperazin-1-yl)ethanone, HCl, Lysine (K)-Specific Demethylase Inhibitor IV,RN-1,HCl, BHC110 Inhibitor IV, KDM1 Inhibitor IV, MOA Inhibitor III)

10mg

MBS3602865

LSD1 inhibitor 24

onrequest

217520-10mg

LSD1 Inhibitor III, CBB1007 (Histone Lysine Demethylase Inhibitor V, CBB1007, KDM1 Inhibitor III, CBB1007, (Methyl-3-(4-(4-carbamimidoylbenzoyl)piperazine-1-carbonyl)-5-((4-carbamimidoylpiperazin-1-yl)methyl)benzoate, BHC110 Inhibitor III, Lysine Specific Demethylase Inhibitor VI)

10mg

orb1818682-100mg

T-448

100mg

‹

›